Related Experiment Video
Updated: Aug 23, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Therapy of hypertension 2004--quo vadis?]
Vjekoslav Gerc1, Marko Buksa, Amila Arslanagić
1Klinika za bolesti srca i reumatizam, KCU Sarajevo, BiH.
Insights
Managing hypertension is challenging. Beta blockers, diuretics, ACE inhibitors, and ARBs offer benefits, but patient adherence remains crucial for successful treatment outcomes.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Context:
- Hypertension management presents ongoing challenges at the start of the 21st century.
- Established treatments like beta-blockers and diuretics reduce cardiovascular events.
- Emerging drug classes targeting the renin-angiotensin system show promise.
Purpose:
- To review current strategies for hypertension management.
- To highlight the benefits of newer antihypertensive agents.
- To address the critical issue of patient adherence to therapy.
Summary:
- Beta blockers and diuretics are proven to reduce mortality and major cardiovascular events in hypertensive patients.
- Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) demonstrate additional benefits, particularly in high-risk individuals, even with normal blood pressure.
- Patient adherence to antihypertensive therapy is paramount for successful management, directly impacting treatment outcomes.
- New European guidelines and JNC 7 recommendations provide a structured approach to hypertension management, incorporating updated perspectives and raising new questions.
Impact:
- Provides an overview of current hypertension management strategies.
- Emphasizes the role of novel pharmacological agents in cardiovascular risk reduction.
- Underscores the importance of patient adherence for effective hypertension control and improved patient outcomes.
Abstract:
Management of hypertension, at the beginning of the new millennium, persists in being a difficult, demanding and responsible task. Beta blockers and diuretics reduce mortality, stroke and coronary disease in patients suffering from arterial hypertension. Newer antihypertensive drugs which block the renin angiotensin system, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), may have additional benefits in high-risk individuals with normal blood pressure. The additional benefit has been confirmed in LIFE and ANBP2 studies. In HOPE study, application of the ACE inhibitors in high-risk patients with "normal" BP values resulted in reduction of major cardiovascular events. Problem of adherence to therapy also continues to be one of the most important problems in management of hypertension. The success of antihypertensive management is directly proportional to the adherence to therapy. The new European guidelines for the management of arterial hypertension and JNC 7 recommendations offer a rational and effective approach to management of hypertension. These two documents contain a series of new attitudes, and reminded of some old and opened some new questions.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies